These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 1665565

  • 21. Effect of hypo- and hyperthyroidism on binding of [3H]-nitrendipine to myocardial and brain membranes.
    Kosinski C, Gross G, Hanft G.
    Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):128S-130S. PubMed ID: 2176516
    [Abstract] [Full Text] [Related]

  • 22. [3H]diltiazem binding to calcium channel antagonists recognition sites in rat cerebral cortex.
    Schoemaker H, Langer SZ.
    Eur J Pharmacol; 1985 May 08; 111(2):273-7. PubMed ID: 2410283
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex.
    Schoemaker H, Langer SZ.
    J Pharmacol Exp Ther; 1989 Feb 08; 248(2):710-5. PubMed ID: 2537412
    [Abstract] [Full Text] [Related]

  • 26. The influence of chronic treatment with antidepressant neuroleptics on the central serotonin system.
    Antkiewicz-Michaluk L.
    Pol J Pharmacol Pharm; 1986 Feb 08; 38(4):359-70. PubMed ID: 3774629
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. SR 33557, a novel calcium-antagonist: interaction with [3H]-(+/-)-nitrendipine and [3H]-(-)-desmethoxy-verapamil binding sites in cerebral membranes.
    Nokin P, Clinet M, Polster P, Beaufort P, Meysmans L, Gougat J, Chatelain P.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Feb 08; 339(1-2):31-6. PubMed ID: 2542806
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The effect of calcium channel blockade on the action of chronic ECT and imipramine on responses of alpha 1- and beta-adrenoceptors in the rat cerebral cortex.
    Nalepa I, Vetulani J.
    Pol J Pharmacol; 1993 Feb 08; 45(2):201-5. PubMed ID: 8401774
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effects of various Ca2+ channel antagonists on morphine analgesia, tolerance and dependence, and on blood pressure in the rat.
    Michaluk J, Karolewicz B, Antkiewicz-Michaluk L, Vetulani J.
    Eur J Pharmacol; 1998 Jul 10; 352(2-3):189-97. PubMed ID: 9716354
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cardiovascular effects of substituted tetrahydroisoquinolines in rats.
    Dong H, Lee CM, Huang WL, Peng SX.
    Br J Pharmacol; 1992 Sep 10; 107(1):262-8. PubMed ID: 1330162
    [Abstract] [Full Text] [Related]

  • 37. Cyclandelate as a calcium modulating agent in rat cerebral cortex.
    Bast A, Leurs R, Timmerman H.
    Drugs; 1987 Sep 10; 33 Suppl 2():67-74. PubMed ID: 3040372
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.